CADL

Candel Therapeutics (CADL)

About Candel Therapeutics (CADL)

Candel Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of viral immunotherapies. Its pipeline includes CAN-2409 and CAN-3110. The company was founded by Estuardo Aguilar-Cordova in 2002 and is headquartered in Needham, MA.

Details

Daily high

$4.95

Daily low

$4.78

Price at open

$4.91

52 Week High

$8.61

52 Week Low

$4.25

Market cap

365.5M

Dividend yield

0.00%

Volume

965,430

Avg. volume

1.4M

P/E ratio

-7.12

Candel Therapeutics News